Zacks: Brokerages Set $6.35 Target Price for CRH Medical Corp (NASDAQ:CRHM)
Shares of CRH Medical Corp (NASDAQ:CRHM) have earned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.
Brokerages have set a 12-month consensus price objective of $6.35 for the company and are predicting that the company will post $0.06 EPS for the current quarter, according to Zacks. Zacks has also assigned CRH Medical Corp an industry rank of 108 out of 265 based on the ratings given to related companies.
Several brokerages have weighed in on CRHM. Canaccord Genuity reissued a “buy” rating on shares of CRH Medical Corp in a report on Monday, July 11th. Zacks Investment Research downgraded CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Monday, September 5th. Finally, CIBC reissued an “outperform” rating on shares of CRH Medical Corp in a report on Tuesday, September 13th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/zacks-brokerages-set-6-35-target-price-for-crh-medical-corp-nasdaqcrhm.html
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of Montreal Can purchased a new position in shares of CRH Medical Corp during the second quarter valued at about $1,258,000. Pacific Ridge Capital Partners LLC purchased a new position in shares of CRH Medical Corp during the second quarter valued at about $1,985,000. TFS Capital LLC purchased a new position in shares of CRH Medical Corp during the second quarter valued at about $138,000. Ativo Capital Management LLC purchased a new position in shares of CRH Medical Corp during the second quarter valued at about $1,076,000. Finally, Sentry Investments Corp. boosted its position in shares of CRH Medical Corp by 1.9% in the second quarter. Sentry Investments Corp. now owns 386,300 shares of the company’s stock valued at $1,943,000 after buying an additional 7,300 shares during the last quarter.
CRH Medical Corp (NASDAQ:CRHM) traded up 0.51% on Tuesday, reaching $3.96. The company’s stock had a trading volume of 1,750 shares. The firm has a 50-day moving average of $3.71 and a 200 day moving average of $3.49. CRH Medical Corp has a 12-month low of $2.15 and a 12-month high of $4.20.
About CRH Medical Corp
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.